Pedro C. Barata, MD, MSc, FACP is the director of Clinical Genitourinary Medical Oncology Research Program at University Hospitals Siedman Cancer Center and associate professor of Medicine at Case Western University in Cleveland, Ohio. He is co-leader of the Genitourinary Disease Team, a medical oncologist, and a renowned clinical trialist. His research interests include experimental therapeutics and molecular profiling of tumors and genomic-based therapies for genitourinary tumors, while his clinical interests include kidney, prostate, and bladder cancers.
Dr. Barata is an active member in numerous professional committees and societies, including the American Urological Association, the American Society of Clinical Oncology, the American Association for Cancer Research, and the Society for Immunotherapy of Cancer. He is the recipient of numerous research and educational grants and has authored and co-authored dozens of publications.
Dr. Barata is American board-certified in Medical Oncology and Internal Medicine. He completed his clinical fellowship in experimental therapeutics in genitourinary tumors at the Cleveland Clinic Taussig Cancer Center in Cleveland, Ohio. During that time, he also rotated at the phase I / Experimental Therapeutics Department at MD Anderson Cancer Center, Houston, Texas. He completed his fellowship in medical oncology at Alameda Santo Dos Capuchos in Portugal, and his medical degree at the University of Lisbon.